A year after HemCon Medical Technologies filed for Chapter 11 reorganization following the loss of a patent fight, the Oregon maker of gels and dressings to control bleeding has been sold. TriStar Wellness Solutions in Connecticut disclosed that it bought the company for $3 million in cash, and now HemCon becomes a TriStar subsidiary. TriStar bills itself as a health and wellness company that targets under-met consumer opportunities in the over-the-counter and professional marketplaces. HemCon CEO Barry Starkman, a Merck ($MRK) and Genentech veteran who came on board last year, will remain in charge but also become a TriStar senior vice president. Release